Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study. (2017)
Attributed to:
MRC Centre for Neurodevelopmental Disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/npp.2016.258
PubMed Identifier: 27857125
Publication URI: http://europepmc.org/abstract/MED/27857125
Type: Journal Article/Review
Volume: 42
Parent Publication: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Issue: 4
ISSN: 0893-133X